Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience

ConclusionThe REP index is an independent prognostic factor for OS and PFS in patients with advanced HCC treated with regorafenib.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research